NCI Wins $9 Million Contract with U.S. Army
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Werewolf Therapeutics sells platform assets to EMD Serono for $33M
NCI, Inc. (NCIT) Tops Q2 EPS by 3c
July 29, 2015 4:49 PM EDTNCI, Inc. (NASDAQ: NCIT) reported Q2 EPS of $0.22, $0.03 better than the analyst estimate of $0.19. Revenue for the quarter came in at $86 million versus the consensus estimate of $83.56 million.
NCI, Inc. sees Q3 2015 EPS of $0.18-$0.20. NCI, Inc. sees Q3 2015 revenue of $80-86 million.
NCI, Inc. sees FY2015 EPS of $0.76-$0.82. NCI, Inc. sees FY2015 revenue of $327-343 million.
NCI continued to post excellent operating results in... More
